Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Healthcare/Life Sciences
Elliott Takes Big Stake in Drugmaker Catalent
The activist is pushing for a shake-up of the contract drug manufacturer’s board. Source link
Elliott Takes Big Stake in Drugmaker Catalent
The activist is pushing for a shake-up of the contract drug manufacturer’s board. Source link
FDA Approves First RSV Drug to Protect All Infants
While the virus often leads to mild, coldlike symptoms, it is the leading cause of hospitalization of infants in the U.S. Source link
Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In.
Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion since about a year ago. Source link
Eli Lilly to Acquire Versanis Bio, Maker of Obesity Treatment
Versanis shareholders could receive as much as $1.925 billion in cash, which will consist of an upfront payment and additional payments if certain milestones are
Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion
Roivant, started by presidential candidate Vivek Ramaswamy, could seal a deal in coming days. Source link
Johnson & Johnson Sues Doctors Over Studies Linking Talc-Based Products and Cancer
Company says the studies played a significant role in lawsuits over its Baby Powder and Shower to Shower products. Source link
Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion
Roivant, started by presidential candidate Vivek Ramaswamy, could seal a deal in coming days Source link
FDA Approves First Over-the-Counter Birth-Control Pill
The Food and Drug Administration approved the first over-the-counter birth-control pill, significantly expanding access to contraception among women across the U.S. Source link
Illumina Fined More Than $400 Million in Europe for Closing Grail Deal Early
The European Union’s antitrust watchdog fined the company with the maximum allowable amount for wrapping up its acquisition of the cancer-test developer while the agency